3Lee MP, Reeves C, Schmitt A, et al. Somatic mutation of TSSCS, a novel imprinted gene from human chromosome 11p15.5[J]. Cancer Res, 1998, 58(18) :4155 -4159.
4Schwienhacher C, Gramantieri L, Scelfo R, et al. Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas [ J ]. Proc Natl Acad Sci USA, 2000, 97(10) :5445-5449.
5Lee M, Sup HanW, Kyoung Kim O, et al. Prognostic value of p16iNK4a and p14ABF gene hypermethylation in human colon cancer[J]. Pathol Bes Pract, 2006, 202 (6) :415 -424.
6Sharma D, Blum J, Yang X, et al. Release of methl CpG binding proteins and histone deaeetylasel from the estrogen receptor α (ER) promoter upon reactivation in ER - negative human breast cancer cells [J]. Mol Endocrinol, 2005, 19(7) :1740 - 1751.
7Rand E, Cedar H. Regulation of imprinting: A multi - tiered process [J]. J Cell Biochem, 2003, 88(2) :400 - 407.
8Gao ZH, Suppola S, Liu J, et al. Association of H19 prorooter methylation with the expression of H19 and IGF -Ⅱ genes in adrenocortical tumors [ J ]. J Clin Endocrinol Metab, 2002, 87(3) :1170 - 1176.
9Hisatomi H, Nagac K, Wakita K, et al. ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis [J]. Oncology,2002, 62(2) :136 - 140.
10Dao D, Frank D, Qian N, et al. IMPT1, an imprinted gene similar to polyspecific transporter and multi - drug resistance genes[ J]. Hum Mol Genet, 1998,7 (4) :597 - 608.